ワシントンにおけるパーキンソン病の臨床試験
ワシントン内の拠点で、パーキンソン病に関する15件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
被験者募集中第2/3相
40歳〜80歳 · 全性別 · 2026/09/28更新 · NCT06976268A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
被験者募集中第2/3相
40歳〜85歳 · 全性別 · 2026/09/21更新 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/21更新 · NCT07005180Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/16更新 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/11更新 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
被験者募集中第2相
30歳〜80歳 · 全性別 · 2026/09/10更新 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/08更新 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
被験者募集中観察研究
45歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07330258A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
被験者募集中第3相
45歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
被験者募集中観察研究健康なボランティア歓迎
30歳以上 · 全性別 · 2026/07/27更新 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
被験者募集中
21歳〜80歳 · 全性別 · 2026/05/28更新 · NCT05292794A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
被験者募集中第1相健康なボランティア歓迎
30歳〜85歳 · 全性別 · 2026/04/20更新 · NCT06809400The Parkinson's Genetic Research Study
- VA Puget Sound Health Care System, Seattle
- University of Washington, Seattle
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2024/05/14更新 · NCT01558479Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
被験者募集中観察研究
19歳以上 · 全性別 · 2022/03/25更新 · NCT02194816ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。